OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 10 filers reported holding PTC THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$4,582,000,000
-17.6%
7,900,000
-24.8%
0.09%
+6.0%
Q3 2016$5,561,000,00010,500,0000.08%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 1,500,000$1,161,0000.55%
OAKTREE CAPITAL MANAGEMENT LP 9,700,000$7,617,0000.12%
LAZARD ASSET MANAGEMENT LLC 10,500,000$8,281,0000.02%
Citadel Advisors 17,350,000$13,603,0000.01%
UBS ASSET MANAGEMENT AMERICAS LLC 15,800,000$12,250,372,0000.01%
AMERIPRISE FINANCIAL INC 15,900,000$12,303,0000.01%
CREDIT SUISSE AG/ 4,005,000$3,099,0000.00%
DEUTSCHE BANK AG\ 485,000$375,0000.00%
View complete list of PTC THERAPEUTICS INC shareholders